In pan-cancer copy number variation (CNV) and mutation analyses from the TCGA database, 456 most of the SLC30 and SLC39 family genes demonstrated gene amplification, especially SLC30A8 , SLC30A1 , SLC30A10 , SLC39A1 , and SLC39A4
Provider access: 24/7 messaging access to licensed providers through a secure patient portal for questions, dosage adjustments, and ongoing support
In a patient with type 2 diabetes who is not at high risk for pancreatitis, medullary thyroid carcinoma, or severe renal impairment, how should semaglutide (Ozempic) and sitagliptin (Januvia) be initiated and titrated together?
Semaglutide, a GLP-1 receptor agonist , is FDA-approved not only for type 2 diabetes but also for chronic weight management in adults who meet specific criteria